ArticleJournal of translational medicine2019

Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients.

Jingyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.